Kalvista Pharmaceuticals Inc (KALV)

Aug 12, 2025

KalVista Pharmaceuticals Announces Maintenance of Orphan Designation for Sebetralstat in European Union - BioSpace

Aug 12, 2025

Aug 11, 2025

KalVista Pharmaceuticals Announces Maintenance of Orphan Designa - GuruFocus

Aug 11, 2025

Aug 06, 2025

FDA approved six NMEs in July - biocentury.com

Aug 06, 2025

Aug 05, 2025

KalVista Pharmaceuticals Grants Stock Options to New Hires - AInvest

Aug 05, 2025

Aug 05, 2025

KalVista Pharmaceuticals shares rise 3.68% premarket after announcing inducement grants to new employees. - AInvest

Aug 05, 2025

Aug 05, 2025

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 4, 2025 - BioSpace

Aug 05, 2025

Aug 04, 2025

Reversal Traders Monitor KalVista Pharmaceuticals Inc. for EntryFundamental Growth Stock Analysis Shows Strength - metal.it

Aug 04, 2025

Aug 04, 2025

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | KALV Stock News - GuruFocus

Aug 04, 2025

Aug 03, 2025

Published on: 2025-08-04 07:21:19 - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are analysts’ price targets for KalVista Pharmaceuticals Inc. in the next 12 monthsBuild wealth steadily with proven stock picks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What institutional investors are buying KalVista Pharmaceuticals Inc. stockRapid wealth creation - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is KalVista Pharmaceuticals Inc. stock overvalued or undervaluedMaximize your portfolio’s earning power - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What analysts say about KalVista Pharmaceuticals Inc. stockInvest confidently with actionable market data - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are the technical indicators suggesting about KalVista Pharmaceuticals Inc.Unstoppable investment returns - Jammu Links News

Aug 03, 2025

Aug 03, 2025

When is KalVista Pharmaceuticals Inc. stock expected to show significant growthAchieve consistent profits with expert strategies - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What drives KalVista Pharmaceuticals Inc. stock priceConsistently profitable trades - Jammu Links News

Aug 03, 2025

Aug 02, 2025

KalVista Pharmaceuticals Inc. Stock Analysis and ForecastUnlock exclusive investment alerts - Jammu Links News

Aug 02, 2025

Aug 01, 2025

What is the risk reward ratio of investing in KalVista Pharmaceuticals Inc. stockAdvanced Screener Growth Plan For Every Investor - Jammu Links News

Aug 01, 2025

Aug 01, 2025

What are KalVista Pharmaceuticals Inc. company’s key revenue driversAI Powered Tracker That Work - Jammu Links News

Aug 01, 2025

Jul 30, 2025

KalVista Pharmaceuticals (KALV) Received Positive Opinion From the European Medicines Agency - MSN

Jul 30, 2025

Jul 29, 2025

Published on: 2025-07-29 19:52:44 - metal.it

Jul 29, 2025

Jul 28, 2025

What makes KalVista Pharmaceuticals Inc. stock price move sharplyTriple Return Setup With Risk Control Explained - beatles.ru

Jul 28, 2025

Jul 28, 2025

Sebetralstat recommended for EU approval for treating HAE attacks - Angioedema News

Jul 28, 2025

Jul 27, 2025

What is the dividend policy of KalVista Pharmaceuticals Inc. stockBreakthrough investment results - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

KalVista Pharmaceuticals Faces Downgrade Due to Shrinking Market and Oral Competitor Threat - AInvest

Jul 27, 2025

Jul 27, 2025

KalVista Pharmaceuticals Ekterly Faces A Shrinking Market And Oral Competitor Threat (Downgrade) - Seeking Alpha

Jul 27, 2025

Jul 25, 2025

Kalvista Pharmaceuticals shares rise 1.17% after-hours following positive CHMP opinion for sebetralstat. - AInvest

Jul 25, 2025

Jul 25, 2025

EMA’s CHMP adopts five orphans - BioCentury

Jul 25, 2025

Jul 25, 2025

What analysts say about KalVista Pharmaceuticals Inc. stock outlookPhenomenal capital gains - Jammu Links News

Jul 25, 2025

Jul 25, 2025

New medicines recommended for approval by EMA’s CHMP - The Pharma Letter

Jul 25, 2025

Jul 25, 2025

KalVista receives CHMP opinion recommending sebetralstat marketing authorization - TipRanks

Jul 25, 2025

Jul 25, 2025

KalVista, Biogen, Ionis get EU positive opinions for key drugs (KALV:NASDAQ) - Seeking Alpha

Jul 25, 2025

Jul 25, 2025

European regulator recommends approval of first oral HAE treatment - Investing.com

Jul 25, 2025

Jul 25, 2025

KalVista Pharma Announces Positive CHMP Opinion For Sebetralstat - Nasdaq

Jul 25, 2025

Jul 25, 2025

KalVista Pharmaceuticals Receives Positive CHMP Opinion for Sebetralstat for the Treatment of Hereditary Angioedema Attacks - Business Wire

Jul 25, 2025

Jul 24, 2025

US FDA Cancer Reviewers Heading For The Exits, Potentially Impacting Review Timelines - insights.citeline.com

Jul 24, 2025

Jul 22, 2025

Is KalVista Pharmaceuticals Inc. a good long term investmentRapid return acceleration - jammulinksnews.com

Jul 22, 2025